Myriad Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Myriad Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer (NCT00387153) | Myriad Therapeutics, Inc. | 2005-08-01 |
Track Myriad Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.